Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$697K Buy
6,513
+26
+0.4% +$2.86K 0.06% 166
2026
Q1
$682K Buy
6,487
+319
+5% +$37.5K 0.07% 153
2025
Q4
$770K Sell
6,168
-40
-0.6% -$4.76K 0.09% 123
2025
Q3
$744K Buy
6,208
+70
+1% +$7.39K 0.1% 126
2025
Q2
$563K Sell
6,138
-211
-3% -$19.2K 0.08% 150
2025
Q1
$559K Buy
6,349
+109
+2% +$10.7K 0.09% 151
2024
Q4
$577K Buy
6,240
+124
+2% +$11.9K 0.09% 139
2024
Q3
$567K Buy
6,116
+128
+2% +$10.7K 0.09% 137
2024
Q2
$449K Buy
5,988
+24
+0.4% +$1.92K 0.08% 146
2024
Q1
$514K Buy
5,964
+6
+0.1% +$459 0.09% 138
2023
Q4
$412K Sell
5,958
-17
-0.3% -$1.03K 0.08% 149
2023
Q3
$327K Buy
5,975
+35
+0.6% +$1.99K 0.07% 160
2023
Q2
$331K Buy
5,940
+21
+0.4% +$1.05K 0.07% 163
2023
Q1
$301K Hold
5,919
0.07% 165
2022
Q4
$236K Buy
5,919
+5,600
+1,755% +$210K 0.06% 182
2022
Q3
$10K Hold
319
﹤0.01% 622
2022
Q2
$11K Hold
319
﹤0.01% 626
2022
Q1
$13K Hold
319
﹤0.01% 633
2021
Q4
$17K Buy
+319
New +$15.7K ﹤0.01% 547
2021
Q3
Sell
-319
Closed -$16K 469
2021
Q2
$16K Buy
+319
New +$16K ﹤0.01% 570

Other funds holding CRH

CVA Family Office's CRH Position: Q2 2026 in Review

CVA Family Office increased its CRH (CRH) stake by 0.4% in Q2 2026, buying an estimated $2.86K and bringing the position to 6,513 shares worth $697K. The position accounts for 0.06% of the portfolio, ranked #166.

CVA Family Office first reported a position in CRH in Q2 2021 and has held it in 20 quarters since. The position peaked at $770K in Q4 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • CVA Family Office held 6,513 shares of CRH worth $697K as of Q2 2026.
  • CVA Family Office bought 26 CRH shares in Q2 2026, an estimated $2.86K.
  • CRH made up 0.06% of CVA Family Office's portfolio in Q2 2026, its #166 holding.
  • CVA Family Office first reported a position in CRH in Q2 2021 and has held it in 20 quarters since.
  • CVA Family Office's CRH position peaked at $770K in Q4 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.